Cargando…
Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
Insulin resistance (IR) is associated with several metabolic disorders, including type 2 diabetes (T2D). The development of IR in insulin target tissues involves genetic and acquired factors. Persons at genetic risk for T2D tend to develop IR several years before glucose intolerance. Several rodent...
Autores principales: | Elsayed, Ahmed K, Vimalraj, Selvaraj, Nandakumar, Manjula, Abdelalim, Essam M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006014/ https://www.ncbi.nlm.nih.gov/pubmed/33815671 http://dx.doi.org/10.4252/wjsc.v13.i3.221 |
Ejemplares similares
-
Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
por: Dupuis, Victoria, et al.
Publicado: (2021) -
Keratinocytes Derived from Patient-Specific Induced Pluripotent Stem Cells Recapitulate the Genetic Signature of Psoriasis Disease
por: Ali, Gowher, et al.
Publicado: (2020) -
Induced pluripotent stem cells free of exogenous reprogramming factors
por: Abujarour, Ramzey, et al.
Publicado: (2009) -
Role of selenium in type 2 diabetes, insulin resistance and insulin secretion
por: Casanova, Pilar, et al.
Publicado: (2023) -
Induced pluripotent stem cells, a giant leap for mankind therapeutic applications
por: Bragança, José, et al.
Publicado: (2019)